NASDAQ: NEWTNewtekone Inc Stock
$10.46-0.61 (-5.51%)
Updated Mar 27, 2026
NEWT Price
$10.46
Fair Value Price
N/A
Market Cap
$301.58M
52 Week Low
$9.12
52 Week High
$14.91
P/E
4.73x
P/B
0.76x
P/S
1.33x
PEG
0.82x
Dividend Yield
9.08%
Revenue
$246.07M
Earnings
$60.51M
Gross Margin
100%
Operating Margin
32.5%
Profit Margin
23.6%
Debt to Equity
5.9
Operating Cash Flow
-$579M
Beta
1.03
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
Apr 1, 2026
NEWT Overview
NewtekOne, Inc. is a financial holding company, which engages in the provision of business and financial solutions. Its brands include Newtek Bank, Newtek Lending, Newtek Payments, Newtek Insurance, Newtek Payroll, and Newtek Technology. The company was founded by Barry Sloane in 1998 and is headquartered in Boca Raton, FL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine NEWT's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Bank
Industry Rating
D
NEWT
Ranked#217 of 280
Ranked#217 of 280
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $5.61 | B | |
| $28.98 | B | |
| $28.37 | B |
Be the first to know about important NEWT news, forecast changes, insider trades & much more!
NEWT News
Overview
Due Diligence Score
–
Industry Average (39)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how NEWT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NEWT ($10.46) is trading below its intrinsic value of $16.14, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NEWT is good value based on its earnings relative to its share price (4.73x), compared to the US market average (30.72x)
P/E vs Market Valuation
NEWT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more NEWT due diligence checks available for Premium users.
Valuation
NEWT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
4.73x
Industry
13.4x
Market
30.72x
NEWT is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
NEWT is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
NEWT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.76x
Industry
1.17x
NEWT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NEWT price to earnings growth (PEG)
For valuing profitable companies with growth potential
NEWT is good value based... subscribe to Premium to read more.
PEG Value Valuation
NEWT's financial health
Profit margin
Revenue
$64.9M
Net Income
$19.5M
Profit Margin
28.5%
NEWT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.7B
Liabilities
$2.3B
Debt to equity
5.9
NEWT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NEWT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$151.4M
Investing
-$51.4M
Financing
$296.2M
NEWT vs Bank Stocks
Newtekone Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.